Zimmer Biomet Holdings, Inc.
MX ˙ BMV ˙ US98956P1021
SecurityMX:ZBH / Zimmer Biomet Holdings, Inc.
InstitutionSummit Trail Advisors, Llc
Latest Disclosed Ownership20,252 shares
Latest Disclosed Value $ 1,831,186
Summit Trail Advisors, Llc reports 62.95% increase in ownership of ZBH / Zimmer Biomet Holdings, Inc.

On May 12, 2026 - Summit Trail Advisors, Llc filed a 13F-HR form disclosing ownership of 20,252 shares of Zimmer Biomet Holdings, Inc. (MX:ZBH) valued at $1,831,186 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 12,428 shares of Zimmer Biomet Holdings, Inc.. This represents a change in shares of 62.95% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ZIMMER BIOMET HOLDINGS COM 98956P102 20,252 7,824 62.95 1,831 63.48 0.0262
2026-02-17 2025-12-31 13F ZIMMER BIOMET HOLDINGS COM 98956P102 12,428 2,456 24.63 1,121 13.94 0.0194
2025-11-14 2025-09-30 13F ZIMMER BIOMET HOLDINGS COM 98956P102 9,972 9,972 983 0.0136
2025-08-14 2025-06-30 13F ZIMMER BIOMET HOLDINGS COM 98956P102 0 -6,345 -100.00 0 -100.00
2025-04-28 2025-03-31 13F ZIMMER BIOMET HOLDINGS COM 98956P102 6,345 1,812 39.97 720 50.10 0.0237
2025-01-29 2024-12-31 13F ZIMMER BIOMET HOLDINGS COM 98956P102 4,533 1,095 31.85 480 29.11 0.0177
2024-11-12 2024-09-30 13F ZIMMER BIOMET HOLDINGS COM 98956P102 3,438 -179 -4.95 372 -5.60 0.0092
2024-08-13 2024-06-30 13F Zimmer HLDGS Inc Com COM 98956P102 3,617 3,617 393 0.0103
2019-02-13 2018-12-31 13F ZIMMER BIOMET HLDGS INC COM EQUITY 98956P102 0 -2,675 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ZIMMER BIOMET HLDGS INC COM EQUITY 98956P102 2,675 1,063 65.94 352 95.56 0.0777
2018-08-10 2018-06-30 13F Zimmer HLDGS Inc Com EQUITY 98956P102 1,612 -126,275 -98.74 180 40.63 0.0629
2018-05-21 2018-03-31 13F ZIMMER BIOMET HLDGS INC COM EQUITY 98956P102 127,887 126,456 8,836.90 128 -27.68 0.0199
2018-02-14 2017-12-31 13F ZIMMER BIOMET HLDGS INC COM EQUITY 98956P102 1,431 1,431 177 0.0224
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.